Susquehanna International Group, LLP Arvinas, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Arvinas, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 65,209 shares of ARVN stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,209

Previous 8,400 676.3%

Holding current value

$1.19 Million

Previous $206,000 506.8%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.83 - $28.04 $1.16 Million - $1.83 Million	65,209 New	65,209 $1.25 Million
Q1 2024 May 07, 2024	SELL	$36.38 - $52.31 $739,132 - $1.06 Million	-20,317 Reduced 76.31%	6,308 $260,000
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $103,757 - $309,516	7,312 Added 37.86%	26,625 $1.1 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $212,956 - $305,881	-10,843 Reduced 35.96%	19,313 $379,000
Q2 2023 Aug 11, 2023	SELL	$21.73 - $31.43 $316,367 - $457,589	-14,559 Reduced 32.56%	30,156 $748,000
Q1 2023 May 16, 2023	SELL	$26.15 - $37.26 $416,517 - $593,477	-15,928 Reduced 26.27%	44,715 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $513,188 - $904,678	15,805 Added 35.25%	60,643 $2.07 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $1.88 Million - $2.6 Million	44,838 New	44,838 $2 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $76,649 - $111,988	1,164 Added 24.41%	5,933 $487,000
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $542,412 - $799,316	-7,410 Reduced 60.84%	4,769 $392,000
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $185,917 - $291,927	-3,195 Reduced 20.78%	12,179 $805,000
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $614,724 - $2.59 Million	-30,447 Reduced 66.45%	15,374 $1.31 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $166,194 - $262,701	7,229 Added 18.73%	45,821 $1.08 Million
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $1.05 Million - $2 Million	-35,239 Reduced 47.73%	38,592 $1.29 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $2.44 Million - $4.02 Million	73,831 New	73,831 $2.98 Million

Others Institutions Holding ARVN

# of Institutions

228

Shares Held

72.8M

Call Options Held

719K

Put Options Held

290K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $974M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Arvinas, Inc. Transaction History